Page last updated: 2024-08-24

ruthenium chloride (rucl3) and Animal Mammary Carcinoma

ruthenium chloride (rucl3) has been researched along with Animal Mammary Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Batista, AA; Caldeira, RP; Correa, RS; da Silva, PFF; de Silveira-Lacerda, EP; Martins-Oliveira, A; Mello-Andrade, F; Pires, WC; Teixeira, T; Travassos, IO	1

Other Studies

1 other study(ies) available for ruthenium chloride (rucl3) and Animal Mammary Carcinoma

Article	Year
Ruthenium (II)/allopurinol complex inhibits breast cancer progression via multiple targets. Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2021, Volume: 26, Issue:4 Topics: Allopurinol; Animals; Antineoplastic Agents; Ascitic Fluid; Cell Cycle; Cell Migration Assays; Cell Survival; Cells, Cultured; Female; Fibroblasts; Humans; Mammary Neoplasms, Animal; Mice; Neoplasms, Experimental; Ruthenium Compounds	2021

Article

Year

Ruthenium (II)/allopurinol complex inhibits breast cancer progression via multiple targets.

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2021, Volume: 26, Issue:4

Topics: Allopurinol; Animals; Antineoplastic Agents; Ascitic Fluid; Cell Cycle; Cell Migration Assays; Cell Survival; Cells, Cultured; Female; Fibroblasts; Humans; Mammary Neoplasms, Animal; Mice; Neoplasms, Experimental; Ruthenium Compounds

2021